Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with CRTX included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Cortexyme doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Cortexyme?
- What is the ticker symbol for Cortexyme?
- Does Cortexyme pay dividends?
- What sector is Cortexyme in?
- What industry is Cortexyme in?
- What country is Cortexyme based in?
- When did Cortexyme go public?
- Is Cortexyme in the S&P 500?
- Is Cortexyme in the NASDAQ 100?
- Is Cortexyme in the Dow Jones?
- When does Cortexyme report earnings?
What is the primary business of Cortexyme?
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
What is the ticker symbol for Cortexyme?
The ticker symbol for Cortexyme is NASDAQ:CRTX
Does Cortexyme pay dividends?
No, Cortexyme does not pay dividends
What sector is Cortexyme in?
Cortexyme is in the Healthcare sector
What industry is Cortexyme in?
Cortexyme is in the Biotechnology industry
What country is Cortexyme based in?
Cortexyme is headquartered in United States
When did Cortexyme go public?
Cortexyme's initial public offering (IPO) was on 09 May 2019
Is Cortexyme in the S&P 500?
No, Cortexyme is not included in the S&P 500 index
Is Cortexyme in the NASDAQ 100?
No, Cortexyme is not included in the NASDAQ 100 index
Is Cortexyme in the Dow Jones?
No, Cortexyme is not included in the Dow Jones index
When does Cortexyme report earnings?
The date for Cortexyme's next earnings report has not been announced yet